Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma

ConditionsAsthma Respiratory Tract Infections Gastrointestinal Infection Croup Eczema Allergy Wheezing Fractures, Bone Development, Child Cognition Disorders in Children Psychiatric Diagnosis

Trial statusRecruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexFemale

Age18-45

SponsorProfessor Klaus Bønnelykke

About this trial

The overall aim of the study is to develop a nutritional preventive fish oil supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that both supplementations in higher doses than recommended could reduce the risk of disease development.

Eligibility criteria

Qualifiers

Pregnant Danish women before week 26 with blood levels of EPA+DHA below 4.7% of total fatty acids

No planned use of fish oil supplementations

No endocrine-, heart-, kidney- or auto-immune disorders

No disorders requiring treatment with blood thinning medication

Disqualifiers

None

Trial design

Treatments tested in this trial

n-3 fatty acid
Rape seed oil

Treatment groups

2,000 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Professor Klaus Bønnelykke

Lead sponsor

Copenhagen Studies on Asthma in Childhood

Sponsor institution

Source ClinicalTrials.gov